Tesamorelin
also known as Egrifta
Growth hormone-releasing peptide for visceral fat reduction.
Nightly subcutaneous tesamorelin, a GHRH analog that stimulates the body's own growth hormone release to reduce visceral abdominal fat and improve body composition, prescribed with baseline and follow-up IGF-1 and metabolic labs.
about 4 minutes. You'll only pay if you're approved and choose a plan.
Plans
You'll pick a plan after the intake. Your card is only charged if a clinician approves your request.
No separate care-team fee.
Low / Starter monthly tier for Tesamorelin, prescribed only when clinically appropriate.
- Monthly supply
- Cancel anytime from your account
No separate care-team fee.
Standard monthly tier for Tesamorelin, prescribed only when clinically appropriate.
- Monthly supply
- Cancel anytime from your account
Available after clinician review — treatment starts on the starting dose.
No separate care-team fee.
High / Intensive monthly tier for Tesamorelin, prescribed only when clinically appropriate.
- Monthly supply
- Cancel anytime from your account
Available after clinician review — treatment starts on the starting dose.
